Created by on 10/15/2012 12:00:00 AM

The Federation of American Societies for Experimental Biology (FASEB) has released the latest article in the Horizons in Bioscience series, “Optogenetics: Illuminating the Brain.” Also available as a podcast, the publication describes the growing field of optogenetics and its contributions toward the development of new treatments for human diseases.
The overwhelming complexity of the brain has long been a shroud, limiting our ability to understand and treat neurological and psychiatric illnesses. With the support of the National Institutes of Health and the National Science Foundation, the emerging field of optogenetics represents a promising new approach to deconstructing that complexity. Researchers, using light-responsive proteins and genetic targeting to control the behavior of highly specific cell populations, are making phenomenal progress in the development of the next generation of new breakthrough therapies for Parkinson’s disease and other devastating human disorders.
The Horizons in Bioscience series describes scientific discoveries on the brink of clinical application. These one page articles are intended to supplement FASEB’s longer-format series, Breakthroughs in Bioscience. Free copies of all of the articles in both series can be obtained from the Breakthroughs and Horizons website.